FDA inspection
PharmaMax Pharmaceuticals, Ltd.: FDA inspection ending Sep 1, 2023
FDA inspection 1221444 · No Action Indicated (NAI) · Taizhou
Key facts
| Inspection ID | 1221444 |
|---|---|
| Firm | PharmaMax Pharmaceuticals, Ltd. |
| FEI number | 3014211046 |
| Address | No 1 Nanbatang Road China, Medical City |
| City | Taizhou |
| Fiscal year | 2023 |
| Inspection end date | Sep 1, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data